Zydus Lifesciences Limited has announced its plans for the upcoming Thirty-First Annual General Meeting (AGM), scheduled for August 11, 2026. The Board of Directors has also recommended a final dividend of Re. 1 per equity share for the financial year ended March 31, 2026. The record date to determine eligible shareholders for the dividend payout is set for July 24, 2026, with payments expected to commence on August 14, 2026.
Upcoming Annual General Meeting
The company has confirmed that it will hold its Thirty-First Annual General Meeting on Tuesday, August 11, 2026. In alignment with modern corporate practices, the meeting will be conducted virtually through Video Conference / Other Audio Visual Means, allowing shareholders to participate remotely.
Dividend Recommendation
During the meeting held on May 19, 2026, the Board of Directors approved a final dividend of Re. 1 per equity share, representing a 100% payout on the face value of the shares. The final disbursement of this dividend remains subject to approval by the members of the company during the upcoming AGM.
Key Dates for Shareholders
Investors should note the following critical dates regarding the dividend distribution:
- Record Date: Friday, July 24, 2026, to determine shareholder eligibility for the dividend.
- Payment Date: Expected on or around August 14, 2026, subject to necessary shareholder approvals at the AGM and after the deduction of applicable taxes at source.
Source: BSE
